RARA and leukemia: The established PML/RARα-positive leukemia was composed of 73% linlo/- cells, 65% of which were already committed Sca1−/c-Kit− cells, 13.5% were Sca1−/c-Kit+ and 1.5% presented the stem-cell phenotype of Sca1+/c-Kit+.